Menu
Fechar
hrs4r
 I want to donate
Firma
JOAN BRUNET-VIDAL
Position
Cap de Grup - R4
Group leader - R4
Projectes
Publicacions

Projectes

Cardiovascular Genetics

Data-driven cancer genome interpretation for personalised cancer treatment

Codi oficial: 101057509 Start date:01/11/2022 Data fi: 31/10/2027 Investigador/a principal: JOAN BRUNET VIDAL, RAMON BRUGADA TERRADELLAS Organisme finançador: EUROPEAN COMISSION Ajuda: 218,975 €
Precision Oncology in Girona

Validación de la utilidad clínica de la evaluación de la inestabilidad de microsatélites con alta sensibilidad en la mejora del diagnóstico precoz de cáncer de endometrio y en el establecimiento de estrategias de seguimiento ginecológico personalizadas en síndrome de Lynch (PROJECTES)

Codi oficial: Inestabilidad de microsatélites con alta sensibilidad Start date:28/04/2023 Data fi: 27/04/2025 Investigador/a principal: JOAN BRUNET VIDAL Organisme finançador: FUND. SEOM Ajuda: 35,000 €
Precision Oncology in Girona

CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

Codi oficial: 101095483 Start date:01/01/2023 Data fi: 31/12/2025 Investigador/a principal: JOAN BRUNET VIDAL Organisme finançador: EUROPEAN COMISSION Ajuda: 200,000 €

Publicacions

Gonzalez-Abuin N, Pons T, Fuster T, Quintana I, Terradas M, Aiza G, Brunet J, Capellá G, Hampel H, Valle L

Lack of evidence for germline WWP1 pathogenic variants in gastrointestinal polyposis and other phenotypes suggestive of PTEN-hamartoma-tumor syndrome.

Genes and Diseases, 2024, 11, 524-527 dx.doi.org/10.1016/j.gendis.2023.03.011
Hendricks LAJ, Hoogerbrugge N, Mensenkamp AR, Brunet J, Lleuger-Pujol R, Høberg-Vetti H, Haavind MT, Innella G, Turchetti D, Aretz S, Spier I, Tischkowitz M, Jahn A, Links TP, Olderode-Berends MJW, Blatnik A, Leter EM, Evans DG, Woodward ER, Steinke-Lange V, Anastasiadou VC, Colas C, Villy MC, Benusiglio PR, Gerasimenko A, Barili V, Branchaud M, Houdayer C, Tesi B, Yazicioglu MO, van der Post RS, Schuurs-Hoeijmakers JHM, PTEN Study Group, Vos JR

Cancer risks by sex and variant type in PTEN Hamartoma Tumor Syndrome.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115, 93-103 dx.doi.org/10.1093/jnci/djac188
Dueñas N, Navarro M, Sanjuán X, Ruiz N, Iglesias S, Matias-Guiu X, Guardiola J, Kreisler E, Biondo S, González S, Legido R, Blanco A, Navarro S, Asiain L, Santos C, Capellá G, Pineda M, Brunet J

Lessons learnt from the implementation of a colorectal cancer screening programme for lynch syndrome in a tertiary public hospital.

CANCER EPIDEMIOLOGY, 2023, 82, 102291-102291 dx.doi.org/10.1016/j.canep.2022.102291
Garcia-Pelaez J, Barbosa-Matos R, Lobo S, Dias A, Garrido L, Castedo S, Sousa S, Pinheiro H, Sousa L, Monteiro R, Maqueda JJ, Fernandes S, Carneiro F, Pinto N, Lemos C, Pinto C, Teixeira MR, Aretz S, Bajalica-Lagercrantz S, Balmaña J, Blatnik A, Benusiglio PR, Blanluet M, Bours V, Brems H, Brunet J, Calistri D, Capellá G, Carrera S, Colas C, Dahan K, de Putter R, Desseignés C, Domínguez-Garrido E, Egas C, Evans DG, Feret D, Fewings E, Fitzgerald RC, Coulet F, Garcia-Barcina M, Genuardi M, Golmard L, Hackmann K, Hanson H, Holinski-Feder E, Hüneburg R, Krajc M, Lagerstedt-Robinson K, Lázaro C, Ligtenberg MJL, Martínez-Bouzas C, Merino S, Michils G, Novakovic S, Patiño-García A, Ranzani GN, Schröck E, Silva I, Silveira C, Soto JL, Spier I, Steinke-Lange V, Tedaldi G, Tejada MI, Woodward ER, Tischkowitz M, Hoogerbrugge N, Oliveira C

Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.

LANCET ONCOLOGY, 2023, 24, 91-106 dx.doi.org/10.1016/S1470-2045(22)00643-X
Casellas-Vidal D, Mademont-Soler I, Sánchez J, Plaja A, Castells N, Camós M, Nieto-Moragas J, Del Mar García M, Rodriguez-Solera C, Rivera H, Brunet J, Álvarez S, Perapoch J, Queralt X, Obón M

ZDHHC15 as a candidate gene for autism spectrum disorder.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2023, 191, 941-947 dx.doi.org/10.1002/ajmg.a.63099
Tagliamento M, Gennari A, Lambertini M, Salazar R, Harbeck N, Del Mastro L, Aguilar-Company J, Bower M, Sharkey R, Dalla Pria A, Plaja A, Jackson A, Handford J, Sita-Lumsden A, Martinez-Vila C, Matas M, Miguel Rodriguez A, Vincenzi B, Tonini G, Bertuzzi A, Brunet J, Pedrazzoli P, D'Avanzo F, Biello F, Sinclair A, Lee AJX, Rossi S, Rizzo G, Mirallas O, Pimentel I, Iglesias M, Sanchez de Torre A, Guida A, Berardi R, Zambelli A, Tondini C, Filetti M, Mazzoni F, Mukherjee U, Diamantis N, Parisi A, Aujayeb A, Prat A, Libertini M, Grisanti S, Rossi M, Zoratto F, Generali D, Saura C, Lyman GH, Kuderer NM, Pinato DJ, Cortellini A, OnCovid Study Group

Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41, 2800-2814 dx.doi.org/10.1200/JCO.22.01667
López-Fernández A, Villacampa G, Salinas M, Grau E, Darder E, Carrasco E, Solanes A, Velasco A, Torres M, Munté E, Iglesias S, Torres-Esquius S, Tuset N, Diez O, Lázaro C, Brunet J, Corbella S, Balmaña J

Role of psychological background in cancer susceptibility genetic testing distress: It is not only about a positive result.

JOURNAL OF GENETIC COUNSELING, 2023, 32, 778-787 dx.doi.org/10.1002/jgc4.1687
Canet-Hermida J, Marín F, Dorca E, Dueñas N, Costa L, Salinas M, Velasco À, Peremiquel-Trillas P, Paytubi S, Ponce J, Fernández S, Martínez JM, Cárdenas L, Taltavull A, Alemany L, Meléndez C, Oliveras G, Vidal A, Capellá G, López-Bonet E, Brunet J, Matias-Guiu X, Pineda M

Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome.

MODERN PATHOLOGY, 2023, 36, 100158-100158 dx.doi.org/10.1016/j.modpat.2023.100158
Cortellini A, Tabernero J, Mukherjee U, Salazar R, Sureda A, Maluquer C, Ferrante D, Bower M, Sharkey R, Mirallas O, Plaja A, Cucurull M, Mesia R, Dalla Pria A, Newsom-Davis T, Van Hemelrijck M, Sita-Lumsden A, Apthorp E, Vincenzi B, Di Fazio GR, Tonini G, Pantano F, Bertuzzi A, Rossi S, Brunet J, Lambertini M, Pedrazzoli P, Biello F, D'Avanzo F, Lee AJX, Shawe-Taylor M, Rogers L, Murphy C, Cooper L, Andaleeb R, Khalique S, Bawany S, Ahmed S, Carmona-García MC, Fort-Culillas R, Liñan R, Zoratto F, Rizzo G, Perachino M, Doonga K, Gaidano G, Bruna R, Patriarca A, Martinez-Vila C, Pérez Criado I, Giusti R, Mazzoni F, Antonuzzo L, Santoro A, Parisi A, Queirolo P, Aujayeb A, Rimassa L, Diamantis N, Bertulli R, Fulgenzi CAM, D'Alessio A, Ruiz-Camps I, Saoudi-Gonzalez N, Garcia Illescas D, Medina I, Fox L, Gennari A, Aguilar-Company J, Pinato DJ

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.

LANCET ONCOLOGY, 2023, 24, 335-346 dx.doi.org/10.1016/S1470-2045(23)00056-6
Sánchez-Heras AB, Ramon Y Cajal T, Pineda M, Aguirre E, Graña B, Chirivella I, Balmaña J, Brunet J, SEOM Hereditary Cancer Working Group and AEGH Hereditary Cancer Committee

SEOM clinical guideline on heritable TP53-related cancer syndrome (2022).

CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25, 2627-2633 dx.doi.org/10.1007/s12094-023-03202-9

Formulari de contacte

About IDIBGI!

 menu